---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-014068"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-08-30T23:59:59+00:00"
generated_at: "2026-06-23T19:14:23.808168+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CytoDyn appoints Ryan Dunlap as director, effective Aug 25, 2022

## Summary
- Ryan Dunlap appointed as director, filling vacancy from Nader Pourhassan's Jan 2022 resignation.
- Expected to join the Audit Committee; Dunlap has over 25 years of finance and operations leadership.
- Currently CFO at Gurobi Optimization; prior CFO at a publicly traded biotech/pharma sales company.
- Compensation consistent with non-employee director policies; includes cash retainers and stock options.
- No family relationships or transactions requiring disclosure under Item 404(a) of Regulation S-K.

## SEC filing metadata
- accession: 0001558370-22-014068
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/0001558370-22-014068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/cydy-20220824x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-014068
- JSON: https://secwatch.observer/filing/0001558370-22-014068.json
- Plain text: https://secwatch.observer/filing/0001558370-22-014068.txt

## Key facts
- Executive change
  Ryan Dunlap was appointed as director at CytoDyn Inc..
  - Action: appointed
  - Role: director
  source text: On August 24, 2022, the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”) approved the appointment of Ryan Dunlap (“Mr. Dunlap”), as a director of the Company, effective August 25, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000155837022014068/0001558370-22-014068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.